Delving Into Participation Patterns in Social Anxiety Studies
Launched by POWER LIFE SCIENCES INC. · Aug 25, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Delving Into Participation Patterns in Social Anxiety Studies," aims to understand the experiences of people with social anxiety who are participating in another clinical trial involving a specific treatment. The main goal is to closely observe how many participants complete the trial and how many choose to withdraw from it. By joining this study, participants will help researchers learn more about social anxiety, which can lead to better treatments for others in the future.
To be eligible for this trial, individuals must be at least 18 years old, have been diagnosed with social anxiety, and plan to enroll in a clinical trial. It’s important to note that individuals who cannot understand or sign the consent form, cannot report their experiences electronically, or are pregnant are not eligible. Participants will have the chance to share their insights and experiences, contributing to important research that could help many others dealing with social anxiety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient has self-identified as planning to enroll in a clinical trial
- • Patient has been diagnosed with social anxiety
- • Patient is a minimum of 18 years or older
- Exclusion Criteria:
- • Patient does not understand, sign, and return consent form
- • Inability to perform regular electronic reporting
- • Patient is pregnant
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported